KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Current Assets (2016 - 2025)

Historic Current Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $2.0 billion.

  • West Pharmaceutical Services' Current Assets rose 2861.32% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 2861.32%. This contributed to the annual value of $2.0 billion for FY2025, which is 2861.32% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' Current Assets stood at $2.0 billion, which was up 2861.32% from $1.8 billion recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Current Assets high stood at $2.0 billion for Q4 2025, and its period low was $1.3 billion during Q1 2021.
  • Over the past 5 years, West Pharmaceutical Services' median Current Assets value was $1.7 billion (recorded in 2022), while the average stood at $1.7 billion.
  • In the last 5 years, West Pharmaceutical Services' Current Assets skyrocketed by 3575.45% in 2021 and then plummeted by 2138.11% in 2024.
  • West Pharmaceutical Services' Current Assets (Quarter) stood at $1.7 billion in 2021, then increased by 10.19% to $1.9 billion in 2022, then rose by 0.88% to $1.9 billion in 2023, then fell by 20.57% to $1.5 billion in 2024, then grew by 28.61% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q4 2025, $1.8 billion for Q3 2025, and $1.7 billion during Q2 2025.